BEDMINSTER, N.J.--(BUSINESS WIRE)--EKR Therapeutics, Inc., a specialty pharmaceutical company focused on providing novel products for the acute-care hospital setting, today announced that Howard Weisman, the Company’s Chairman and Chief Executive Officer, has been invited to present at the 27th Annual J.P. Morgan Healthcare Conference.
